Welcome to our dedicated page for UBS ETRACS Alerian MLP ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.
UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.
For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.
On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.
UBS AG plans to offer Trigger Callable Contingent Yield Notes linked to the least performing of the Nasdaq‑100 Technology Sector Index, the Russell 2000 Index, and the S&P 500 Index, maturing on October 19, 2028. The Notes pay a contingent coupon of 8.50% per annum on monthly coupon dates only if each index closes at or above its coupon barrier set at 70% of its initial level. UBS may call the Notes in whole on any monthly observation date after six months; if called, holders receive principal plus any due coupon.
If the Notes are not called, and on the final valuation date each index is at or above its downside threshold (also 70% of initial), investors receive the $1,000 principal. If any index finishes below its downside threshold, the maturity payment equals $1,000 × (1 + return of the least performing index), which can result in significant loss, up to total loss. These unsecured obligations depend on UBS’s credit. The estimated initial value is expected between
UBS AG plans a primary offering of Trigger Callable Contingent Yield Notes linked to the least performing of the Dow Jones Industrial Average, the Nasdaq‑100 Technology Sector Index, and the Russell 2000 Index, maturing on or about October 26, 2028. The Notes pay a contingent coupon only if each index closes at or above its coupon barrier on monthly observation dates; otherwise no coupon is paid. UBS may, at its discretion, call the Notes in whole on any observation date beginning after 6 months; if called, investors receive the $1,000 principal per Note plus any due coupon, and the Notes terminate.
At maturity, if not called and each index finishes at or above its downside threshold, investors receive the $1,000 principal. If any index finishes below its downside threshold, the repayment is reduced by the negative return of the worst index, and investors could lose all principal. The indicative terms include a 9.90% per annum contingent coupon rate, coupon barriers at 70.00% of initial levels, and downside thresholds at 55.00% of initial levels. The issue price is $1,000 per Note, with an underwriting discount of $6.00 and proceeds to UBS of $994.00 per Note. The estimated initial value is expected between $959.00 and $989.00. Payments are subject to UBS credit; the Notes are not listed.
UBS AG is offering $2,799,000 of Trigger Callable Contingent Yield Notes linked to the least performing of the Dow Jones Industrial Average, the Nasdaq-100 Technology Sector Index and the Russell 2000 Index, due October 19, 2028.
The Notes pay a 10.00% per annum contingent coupon on monthly observation dates only if each index closes at or above its coupon barrier (70% of its initial level). UBS may call the Notes, in whole, on any observation date beginning after 3 months, paying principal plus any contingent coupon then due.
If not called, and each index finishes at or above its downside threshold (60% of its initial level) on the final valuation date, investors receive the $1,000 principal per Note. If any index finishes below its downside threshold, repayment is reduced one-for-one with the worst performer and could be zero. The Notes are unsecured obligations of UBS and payments depend on its credit. They will not be listed, and liquidity may be limited.
The issue price is $1,000 per Note; the estimated initial value is $981.80 per Note.
UBS AG amended its preliminary pricing supplement for Trigger Autocallable Contingent Yield Notes linked to the common stock of Moderna, Inc., due on or about October 14, 2026. The Notes pay contingent coupons only if the underlying closes at or above a coupon barrier on each observation date, and may be called early if the underlying closes at or above the initial level before the final valuation date.
If not called, principal is repaid at maturity only if the final level is at or above the downside threshold; otherwise, repayment is reduced in line with the underlying’s decline and could be zero. All payments are subject to UBS’s creditworthiness. The Notes will not be listed on any exchange.
Key dates include a trade date of October 9, 2025, settlement on October 14, 2025, a final valuation date of October 12, 2026, and maturity on October 14, 2026. The minimum investment is 100 Notes at $10 per Note. The estimated initial value per $10 Note is expected to be between $9.57 and $9.82. Initial delivery is T+2, which differs from typical T+1 secondary settlement.
UBS AG is offering Trigger Callable Contingent Yield Notes linked to the least performing of the Russell 2000 Index, the S&P 500 Index, the iShares 20+ Year Treasury Bond ETF (TLT) and the Utilities Select Sector SPDR Fund (XLU), maturing on or about October 17, 2030. The notes pay a 10.00% per annum contingent coupon on monthly observation dates only if each underlying is at or above its coupon barrier. UBS may call the notes, in whole, on any observation date beginning after 3 months; if called, holders receive principal plus any due coupon.
If not called and each final level is at or above its downside threshold, investors receive principal at maturity; otherwise, repayment is reduced by the negative return of the least performing underlying, potentially to zero. Barriers are set at 70% of initial level and downside thresholds at 60% of initial level. Issue price is $1,000 per note, with a $6.00 underwriting discount and $994.00 proceeds to UBS. The estimated initial value is expected between $930.50 and $960.50. The notes are unsecured obligations of UBS, will not be listed, and are subject to UBS credit risk.
UBS AG filed a preliminary pricing supplement for Trigger Callable Contingent Yield Notes linked to Constellation Energy Corporation (CEG), maturing on or about October 19, 2028. The Notes pay a 14.60% per annum contingent coupon when the stock closes at or above the coupon barrier on quarterly observation dates and are callable after 6 months at UBS’s discretion.
Both the coupon barrier and downside threshold are set at 52.50% of the initial level. If not called and the final level is below the downside threshold, the maturity payment will reflect the full negative return of the underlying, up to total loss of principal. The estimated initial value is expected between $938.80 and $968.80 per $1,000 Note. Per-Note economics include a $1,000 issue price, $23.50 underwriting discount and $976.50 proceeds to UBS.
The Notes are unsecured obligations of UBS and will not be listed. Any payment depends on UBS’s credit. Quarterly observation and coupon dates run from January 2026 through the final valuation date on October 16, 2028.
UBS AG is offering $5,424,000 of Trigger Jump Securities with an auto‑call feature tied to the worst‑performing of the S&P 500 (initial level 6,552.51) and Russell 2000 (initial level 2,394.595), maturing on October 16, 2031.
The notes pay no interest. On any determination date before maturity, if both indices close at or above their initial levels, the notes are automatically redeemed at $1,000 plus a premium that steps up based on ~8.30% per annum. If held to maturity and both indices finish at or above initial, investors receive $1,498.00 per $1,000. If any index finishes below initial but both remain at or above 80% of initial (5,242.01 for the S&P 500; 1,915.676 for the Russell 2000), investors receive $1,000. If any index finishes below its 80% downside threshold, repayment is reduced one‑for‑one with the worst performer and can be zero.
Issue price is $1,000 per note; total fees are 3.50% (3.00% sales, 0.50% structuring), with proceeds to UBS of 96.50%. The estimated initial value is $950.10. The notes are unsecured obligations of UBS AG, will not be listed, and are subject to UBS credit risk.
UBS AG is offering $1,985,000 of Trigger Autocallable Contingent Yield Notes linked to Meta Platforms common stock, maturing on October 19, 2028. The notes pay a 13.15% per annum contingent coupon only when META’s closing level on a quarterly observation date is at or above the coupon barrier of $496.06 (70% of the initial level).
The notes are automatically called if META is at or above the call threshold of $708.65 (100% of the initial level) on any observation date before final maturity, returning principal plus the applicable coupon. If not called, and META’s final level is at or above $496.06, holders receive principal at maturity. If the final level is below $496.06, the maturity payment is reduced one-for-one with META’s decline, and investors could lose all principal.
Issue price is $1,000 per note; estimated initial value is $973.00. Underwriting discount is $20.00 per note, for proceeds to UBS of $980.00 per note. Payments depend on UBS’s credit. The notes will not be listed.
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the common stock of Moderna, Inc., due October 14, 2026. The notes pay a contingent coupon only if the underlying closes on each observation date at or above a coupon barrier; otherwise no coupon is paid. The notes will be automatically called if the underlying closes at or above the initial level on any observation date before the final valuation date, returning principal plus any due coupon.
If not called, and the final level is at or above the downside threshold, investors receive principal at maturity; if below, repayment is reduced one-for-one with the underlying’s decline, and investors could lose all principal. Payments are subject to UBS credit risk. Key dates: trade date October 9, 2025, settlement October 14, 2025, final valuation October 12, 2026, maturity October 14, 2026. The notes are offered at $10 per Note (minimum 100 Notes) and have an estimated initial value of $9.81. The notes will not be listed.
UBS AG plans to offer Trigger Callable Contingent Yield Notes linked to the least performing of the Dow Jones Industrial Average, Nasdaq‑100, and Russell 2000. The Notes pay a contingent coupon only if each index closes at or above its coupon barrier on the monthly observation date; otherwise no coupon is paid. UBS may call the Notes, in whole, on any observation date beginning after 3 months, returning principal plus any due coupon. If not called and each index finishes at or above its downside threshold at maturity, investors receive principal back.
If any index finishes below its downside threshold at maturity, the repayment is reduced by that index’s percentage decline, up to total loss of principal. Key terms include a contingent coupon rate of 10.75% per annum, coupon barriers and downside thresholds at 70.00% of initial levels, monthly observations, expected trade date October 24, 2025, and maturity on or about October 28, 2027. Issue price is $1,000 per Note, with an underwriting discount of $6.50 and proceeds to UBS of $993.50 per Note. The estimated initial value is expected between $961.50 and $991.50, and payments are subject to UBS credit risk.
FAQ
What is the current stock price of UBS ETRACS Alerian MLP ETN Series B (AMUB)?
